Skip to content
HomeLatest newsJohnson & Johnson named a 2017 Fortune’s Most Admired Company
Johnson & Johnson Credo Wall

Johnson & Johnson named a 2017 Fortune’s Most Admired Company

A commitment to health, caring and employee growth helps make the company so great—and so great to work for.

The results are in: Johnson & Johnson has made Fortune’s Most Admired Companies list for 2017, based on nine criteria, including investment value and social responsibility. This year, Johnson & Johnson ranked #13 on the list overall—up two spots from last year—and took first place in the Pharmaceutical category worldwide. The company also ranked first in all nine key attributes of reputation, which influence rankings on the list—helping to make it one of the best companies to work for.

All of this should come as no surprise to its 127,000 employees.

At the company’s heart is its Credo, which outlines Johnson & Johnson’s mission to put people’s needs front and center. And that includes not only the people who the company helps serve, but also those who make up its workforce.

Employees at Johnson & Johnson can take advantage of a wide range of benefits that speak to the company’s commitment to caring and inclusivity.

For example, Johnson & Johnson recently expanded its parental leave policy in the U.S. to give new mothers up to 17 weeks of paid leave during the first year of birth, and eight weeks of paid leave for all new parents, including those who adopt.

In 2016, insurance coverage for fertility in the U.S. was extended to same-sex couples, and adoption reimbursement benefits were increased to up to $20,000 per child. And moms worldwide who travel for work can also take advantage of a new program that ships breast milk safely home. On a broader scale, Johnson & Johnson remains dedicated to improving the well-being of people around the world through its work with newborn and child health, HIV/AIDS, tuberculosis and more—all with the aim of giving the most vulnerable populations access to the care and treatment they need.

Paramount to that effort is a healthy healthcare workforce, which Johnson & Johnson is helping to strengthen in a number of ways, from supporting nurses and nursing students through scholarships and continuing education to training midwives.

Johnson & Johnson is thrilled that Fortune has recognized once more how it is helping to change the world—by putting people, and their good health, first.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.